Project Grant R01AI189475
Award Date
5/7/25
Completion Date
4/30/30
Dollars Obligated
$558K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to New York University School of Medicine. The $246,623 grant, with a project period from November 20, 2024 to October 31, 2026, will support research to investigate the molecular control of tolerogenic dendritic cell function. The project aims to pinpoint the specific dendritic cell subsets responsible for maintaining immune...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $417,984 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Scripps Research Institute in La Jolla, California. The grant, with a performance period from March 7, 2025 to February 28, 2026, supports research aimed at identifying actionable targets for the selective induction of regulatory T cell (Treg) differentiation to facilitate the development of stem cell-based therapies...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $800,005 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on the structural basis and functional mechanisms of G-protein coupled receptor (GPCR) variants associated with autoimmune diseases. The key objectives of this 5-year project (11/21/2024 - 10/31/2029) are to: 1) define...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $586,250 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Massachusetts Medical School (UMass Medical) to support research on the differentiation and regulation of TFH13 cells, a novel T cell subset that drives the production of high-affinity, pathogenic IgE antibodies in allergic diseases. The overarching goal is to elucidate the immunological requirements for...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $938,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Yale University. The grant, titled "Identification of Novel Regulators for Neutrophil Development and Lifespan," aims to conduct a comprehensive genetic screen to identify new mechanisms that regulate neutrophil development and lifespan. The research will leverage immortalized mouse hematopoietic progenitor...
This $239,348 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate a newly identified population of CD1a-restricted T cells that respond to the lipid antigen phosphatidylglycerol (PG). The researchers at The Trustees of Columbia University in the City of New York will examine the conditions under which mitochondrial PG becomes visible to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $162,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis to characterize the role of plasmacytoid dendritic cells (pDCs) in Mycobacterium tuberculosis (MTB) infection. The project aims to quantify pDC lung trafficking during MTB infection, identify the chemokine receptor required for pDC lung homing, and define pDC's contribution to MTB...
This $658,657 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the biophysical and functional coupling between protein condensates and ordered lipid domains in T-cells. The grant aims to reveal fundamental mechanisms of how protein condensates, which regulate T-cell signaling, interact with membrane lipid nanodomains to influence T-cell...
This Project Grant award of $709,019 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research into the role of the FOXP3 isoform in the development of systemic lupus erythematosus (SLE). The research aims to determine how the expression of the FOXP3 exon 2 isoform leads to regulatory T cell dysfunction and loss of immune tolerance, resulting in the autoantibody production and other...
This federal Project Grant award, totaling $276,450, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding will support a research project entitled "The Role of PPARδ-Controlled CIITA/MHCII Expression in Treg's Function in Tumor Immunity" at The Salk Institute for Biological Studies in La Jolla, California. The research aims to define the role of the PPARδ/CIITA/MHCII...